Skip to main content

Movers & Shakers: Aug 13, 2010


German biotech firm Scil Proteins announced this week the appointment of Andreas Menrad, Jurgen Wahl, and Ranier Kroell to its advisory board.

Menrad is vice president of antibody therapeutics at Genzyme's European research site in Cambridge, UK. Previously he was Genzyme's director of research and development and the director of antibody engineering and anti-angiogenesis research at Schering.

Wahl is the former head of biotech production at Roche where he worked for 22 years.

Kroell is the co-founder of GKK Partners, a Munich-based tax consultation and auditing firm.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.